Jasper Therapeutics JSPR
NASDAQ JSPR
$0.70 +0.01 (+2.02%)
At close: Sep 10, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Amortizatization of Intangibles (2021 - 2023)

Jasper Therapeutics (JSPR) posted Amortizatization of Intangibles of $102000.0 for Q2 2023, up 3.03% on a QoQ basis from $99000.0 in Q1 2023, and up 7.37% year-over-year from $95000.0 in Q2 2022.

Analysis

Jasper Therapeutics (JSPR) Amortizatization of Intangibles (2021 - 2023) Analysis & Trends

Jasper Therapeutics has reported Amortizatization of Intangibles for 3 years, with the latest figure at $102000.0 in Q2 2023.

  • On a quarterly basis, Amortizatization of Intangibles rose 7.37% year-over-year to $102000.0 in Q2 2023; TTM through Jun 2023 was $385000.0, a 146.79% increase from a year earlier, with the FY2022 full-year figure at $335000.0, up 77.25% from the prior year.
  • Amortizatization of Intangibles was $102000.0 for Q2 2023 at Jasper Therapeutics, up from $99000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $102000.0 in Q2 2023, with the low at -$31000.0 in Q3 2021.
  • Average Amortizatization of Intangibles over 3 years is $72500.0, with a median of $92000.0 recorded in 2022.
  • The largest YoY upside for Amortizatization of Intangibles was 390.32% in 2022 against a maximum downside of 41.67% in 2022.
  • Over 3 years, Amortizatization of Intangibles stood at $36000.0 in 2021, then surged by 161.11% to $94000.0 in 2022, then rose by 8.51% to $102000.0 in 2023.
  • The last three Amortizatization of Intangibles figures came in at $102000.0 (Q2 2023), $99000.0 (Q1 2023), and $94000.0 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.39 Mn
10 Jasper Therapeutics 20.11 Mn 20.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 102,000.00
Mar 31, 2023 99,000.00
Dec 31, 2022 94,000.00
Sep 30, 2022 90,000.00
Jun 30, 2022 95,000.00
Mar 31, 2022 56,000.00
Dec 31, 2021 36,000.00
Sep 30, 2021 -31,000.00
Jun 30, 2021 88,000.00
Mar 31, 2021 96,000.00